Boston Scientific (BSX) Free Cash Flow (2009 - 2026)

Boston Scientific has disclosed Free Cash Flow across 18 years of filings, most recently posting $171.0 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $171.0 million, down 51.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 15.3% YoY), and the FY2025 annual result was $3.7 billion, up 38.3% from the prior year.
• Free Cash Flow came in at $171.0 million for Q1 2026 at Boston Scientific, down from $1.0 billion in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.2 billion in Q4 2024 to a low of -$179.0 million in Q1 2022.
• The 5-year median for Free Cash Flow is $515.0 million (2023), against an average of $541.4 million.
• Across the five-year window, Free Cash Flow sank 185.65% in 2022 and soared 2460.0% in 2025, its largest moves.
• Boston Scientific's Free Cash Flow stood at $595.0 million in 2022, then gained by 15.97% to $690.0 million in 2023, then surged by 70.87% to $1.2 billion in 2024, then slipped by 14.08% to $1.0 billion in 2025, then plunged by 83.12% to $171.0 million in 2026.
• The last three Free Cash Flow figures came in at $171.0 million (Q1 2026), $1.0 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.